302 related articles for article (PubMed ID: 31340569)
1. Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin.
Walker DG; Lue LF; Beach TG; Tooyama I
Cells; 2019 Jul; 8(7):. PubMed ID: 31340569
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains.
Walker DG; Tang TM; Mendsaikhan A; Tooyama I; Serrano GE; Sue LI; Beach TG; Lue LF
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968618
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.
Walker DG; Tang TM; Lue LF
Exp Neurol; 2018 Nov; 309():91-106. PubMed ID: 30076830
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues.
Yamada T; Horisberger MA; Kawaguchi N; Moroo I; Toyoda T
Neurosci Lett; 1994 Nov; 181(1-2):61-4. PubMed ID: 7898772
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.
Pey P; Pearce RK; Kalaitzakis ME; Griffin WS; Gentleman SM
Acta Neuropathol Commun; 2014 Feb; 2():21. PubMed ID: 24528486
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.
de Almeida EJR; Ibrahim HJ; Chitolina Schetinger MR; de Andrade CM; Cardoso AM
Neurochem Res; 2022 Nov; 47(11):3221-3240. PubMed ID: 35962936
[TBL] [Abstract][Full Text] [Related]
8. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
[TBL] [Abstract][Full Text] [Related]
9. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
11. Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology?
Kacířová M; Zmeškalová A; Kořínková L; Železná B; Kuneš J; Maletínská L
Clin Sci (Lond); 2020 Mar; 134(5):547-570. PubMed ID: 32167154
[TBL] [Abstract][Full Text] [Related]
12. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Walker DG; Lue LF
J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.
Walker DG; Dalsing-Hernandez JE; Campbell NA; Lue LF
Exp Neurol; 2009 Jan; 215(1):5-19. PubMed ID: 18938162
[TBL] [Abstract][Full Text] [Related]
14. TMEM119 marks a subset of microglia in the human brain.
Satoh J; Kino Y; Asahina N; Takitani M; Miyoshi J; Ishida T; Saito Y
Neuropathology; 2016 Feb; 36(1):39-49. PubMed ID: 26250788
[TBL] [Abstract][Full Text] [Related]
15. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.
Walker DG; Lue LF
Alzheimers Res Ther; 2015 Aug; 7(1):56. PubMed ID: 26286145
[TBL] [Abstract][Full Text] [Related]
16. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
17. Microglia in Alzheimer's disease.
Hansen DV; Hanson JE; Sheng M
J Cell Biol; 2018 Feb; 217(2):459-472. PubMed ID: 29196460
[TBL] [Abstract][Full Text] [Related]
18. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG
Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825
[TBL] [Abstract][Full Text] [Related]
19. Role of cytokines in inflammatory process in Parkinson's disease.
Sawada M; Imamura K; Nagatsu T
J Neural Transm Suppl; 2006; (70):373-81. PubMed ID: 17017556
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains.
Walker DG; Lue LF; Beach TG
Brain Res; 2002 Feb; 926(1-2):69-79. PubMed ID: 11814408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
